Theravia GM26SA01 GCS 2026/ALM
€343,997
Award value
Theravia
4 contracts won, worth €1.2M, from 3 public buyers.
Main sectors Medical equipment & pharmaceuticals 4
Follow this company
We email you when this company wins a new contract. Free, one click to stop.
Relations
Who this company works for
- Centre Hospitalier Universitaire de Toulouse 2 contracts €679,206
- Centre Hospitalier de Valenciennes 1 contract €343,997
- Groupe hospitalier de la region de mulhouse et sud alsace 1 contract €140,157
Shares of the 4 contracts this company has won.
Radar
Contracts expiring soon
Contracts this company holds that end within the next two years. The specification for the replacement is usually shaped 18 to 26 months before the notice appears.
-
Hydroxycarbamide forme orale - indication drepanocytose
€40,000 current contract
7 months
May 2027
Register
Contracts won
Each bar compares an award with the largest on this page, €639,206.
Miglustat oral
€639,206
Award value
Fourniture de medicaments anti infectieux
€140,157
Award value
Hydroxycarbamide forme orale - indication drepanocytose
€40,000
Award value